bpc-157 compounding restrictions fda advisory committee votes to add popular peptide to drug list Hims & Hers Stock Jumps
Hims & Hers Stock Jumps as FDA Panel Opens the Door to a Multibillion Dollar Peptide Market PRISM MarketView Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA panel votes to place popular peptide BPC 157 on compounding list Reuters FDA Advisers Vote to Ease Restrictions on BPC 157, TB 500, and Other Novel Peptides Glitchwire Industry Update: Interim 503A and 503B Bulks Lists New Revisions FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



